Armata Pharmaceuticals Statistics
NYSE: ARMPHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
3.03+0.05 (+1.68%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Armata Pharmaceuticals by the numbers
Armata Pharmaceuticals has a market capitalization of $112.7 million based on 37.19M shares outstanding. With trailing EPS of $-4.17, Armata Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.4% below its 50-day average and 55.2% below its 200-day average.
Average daily trading volume is 182.52K shares, or about $553,030 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ARMP valuation vs. peer median
| Metric | ARMP | Peer median | Difference |
|---|---|---|---|
| Market cap | $112.69M | $114.21M | -1% |
| Avg. volume | 182.52K | 1.37M | -87% |
Peer median across 8 companies: FATE, CRDL, ENGN, IVVD, HUMA, CMPX, MOLN, IPHA.
Valuation
- Market cap
- $112.69M
- EPS (TTM)
- $-4.17
- Shares outstanding
- 37.19M
Price and trading
- Previous close
- 2.98
- Open
- 2.92
- Day range
- 2.89 – 3.19
- 52-week range
- 2.40 – 14.98
- 52-week change
- -56.90%
- Beta
- —
- Volume
- 85.64K
- Average volume
- 182.52K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 112.69M
- Forward Pe
- -1.49
- Eps
- -4.17
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 14.98
- Week52 Low
- 2.40
- Avg Volume
- 182.52K
- Shares Outstanding
- 37.19M
- Ma50
- 3.54
- Ma200
- 6.76
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -79.77%
- Pct From52w Low
- 26.25%